<DOC>
	<DOCNO>NCT00740727</DOCNO>
	<brief_summary>Test whether Basic Life Support ( BLS ) provider successfully place Enzymatically Augmented Subcutaneous Infusion ( EASI ) Access line subcutaneous infusion , characterize intravascular absorption EASI-administered ( tracer-labelled ) glucose ( D5W ) .</brief_summary>
	<brief_title>EASI Access II -- - Follow-up Study EASI Access Trial</brief_title>
	<detailed_description />
	<mesh_term>Dehydration</mesh_term>
	<criteria>Subjects least 18 year age none follow condition : pregnancy ( negative urine pregnancy test perform study participation ) , diabetes , coagulopathic ( include take anticoagulant ) ; Subjects take steroids immunosuppressant . Because potential reduced hyaluronidase effectiveness , study excludes patient take 80 mg daily aspirin , well patient take ACTH , antihistamine , estrogen oral contraceptive preparation . Subjects require fast study , allow eat drink EASI infusion phlebotomy sample time frame .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Disaster</keyword>
	<keyword>Mass casualty incident</keyword>
	<keyword>Prehospital</keyword>
	<keyword>Rehydration</keyword>
	<keyword>Intravascular access</keyword>
</DOC>